Approval · Notice of Compliance 5028 · 1995
FLUANXOL: Notice of Compliance 5028
Issued March 6, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5028
- Date
- March 6, 1995
- Company
- Lundbeck Canada IncSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antipsychotic
Products in this notice
Medicinal ingredients
- FLUPENTIXOL DECANOATE 20 MG per ML
- FLUPENTIXOL DECANOATE 100 MG per ML